April 11 (Reuters) - Seres Therapeutics Inc:
* Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc As Of April 10, 2018 - SEC Filing Source text (bit.ly/2GSzKlq) Further company coverage: (Reuters.Briefs@thomsonreuters.com)